Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
ONLY AVAILABLE IN PAID PLANS
Related
South Korea’s LetinAR is building optics behind AI glasses
A lens the size of a thumbnail — and the South Korean startup that makes it could become the optical backbone of the AI glasses era.
India missed out on AI and now its run as market darling may be over
India faces a significant setback as artificial intelligence reshapes global investments. The nation's stock market is nearing a fall from the world's top five. Unlike Taiwan and S...
Customs CG urges ethical AI use, stronger human oversight in digital era
The Comptroller-General of the Nigeria Customs Service, Adewale Adeniyi, has urged a human-centred approach to digital transformation, warning that technology must enhance, not rep...